WebMD

Managing Multiple Sclerosis With Briumvi: What You Need to Know

Briumvi is a medicine used to treat relapsing forms of multiple sclerosis (MS). Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS.
WebMD

Managing Multiple Sclerosis With Kesimpta: What You Need to Know

Kesimpta is a medicine used to treat relapsing forms of multiple sclerosis (MS). Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS ...
Everyday Health

FDA Approves Briumvi to Treat Relapsing Multiple Sclerosis

On December 28, 2022, the U.S. Food and Drug Administration (FDA) approved Briumvi (ublituximab), a disease-modifying therapy (DMT) to treat relapsing forms of multiple sclerosis (RMS) in adults, ...
The American Journal of Managed Care

Identifying Signs of Presymptomatic MS, Radiologically Isolated Syndrome

Radiologically isolated syndrome (RIS) involves MS-like lesions on MRI without clinical symptoms, with a significant risk of progression to MS. Updated 2023 RIS criteria improve diagnostic accuracy, ...
Medscape

High-Dose Vitamin D Curbs Disease Activity in Early Multiple Sclerosis

High-dose oral cholecalciferol (vitamin D3) supplementation significantly reduced disease activity in patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) in the ...
Healio

Multiple Sclerosis Treatment Guidelines

Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...